Eisai currently works across Europe in the areas of Alzheimer’s disease, gastro-intestinal disorders, epilepsy, cervical dystonia, severe chronic pain and oncology.

Product Overview

Click on the brand name below for further information and related links

Aricept®

donepezil hydrochloride

For the treatment of Alzheimer's disease

Click here to view Aricpet product details

Pariet®

rabeprazole sodium

For the treatment of gastric acid-related disorders

Click here to view Pariet product details

Zonegran®

zonisamide

For the treatment of adult patients with partial-onset seizures

Click here

Inovelon®

rufinamide

For the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS)

Click here to view Inovelon product details

NeuroBloc®

botulinum toxin type B

For the treatment of cervical dystonia (torticollis)

Click here to view NeuroBlock product details

Prialt®

ziconotide

For the treatment of severe, chronic pain

Click here to view Prialt product details

Zebinix®

eslicarbazepine acetate

For the treatment of adult patients with partial-onset seizures

Click here to view Zebinix product details

 

Halaven®

eribulin mesylate

For the treatment of locally advanced or metastatic breast cancer

Click here to view Halvalen product details

 


 

 

 

 

 

Fycompa®

perampanel

For the treatment of  patients aged 12 years and older with partial onset seizures

Click here to view Halvalen product details

 

Understanding the future information for investors